Un ‘páncreas artificial’ mejora el control del azúcar en la sangre en los niños con diabetes tipo 1
VIERNES, 17 de marzo de 2023 (HealthDay News) — Igual que los adultos, los niños pequeños con diabetes tipo 1 podrían experimentar el mejor control que necesitan del azúcar en la sangre mediante el uso de un “páncreas artificial”, muestra una investi…
Learn MoreClosed-Loop Glucose System Beneficial for Young Children With Type 1 Diabetes
FRIDAY, March 17, 2023 (HealthDay News) — For young children with type 1 diabetes, a closed-loop glucose system results in a higher percentage of time that the glucose level is in the target range, according to a study published in the March 16 issue…
Learn MoreClosed-Loop Glucose System Beneficial for Young Children With Type 1 Diabetes
FRIDAY, March 17, 2023 (HealthDay News) — For young children with type 1 diabetes, a closed-loop glucose system results in a higher percentage of time that the glucose level is in the target range, according to a study published in the March 16 issue…
Learn More‘Artificial Pancreas’ Technology Boosts Blood Sugar Control for Young Kids With Type 1 Diabetes
FRIDAY, March 17, 2023 (HealthDay News) — Just like adults, young children with type 1 diabetes may get the blood sugar control they need using an “artificial pancreas,” new research shows. The Control-IQ artificial pancreas system was tested in a cl…
Learn MoreLas tasas de diabetes siguen en aumento entre los estadounidenses jóvenes
JUEVES, 9 de marzo de 2023 (HealthDay News) — Una preocupante nueva investigación encuentra que las tasas de diabetes tipo 1 y tipo 2 siguen en aumento entre los niños y los adultos jóvenes.Los niños asiáticos o de las Islas del Pacífico, los negros …
Learn MoreDiabetes Rates Keep Rising Among Young Americans
THURSDAY, March 9, 2023 (HealthDay News) — Troubling new research finds that rates of type 1 and type 2 diabetes are continuing to increase in children and young adults.Asian or Pacific Islander, Black and Hispanic children had higher rates, the stud…
Learn MoreVerapamil Partially Preserves C-Peptide Secretion in Children With T1DM
TUESDAY, March 7, 2023 (HealthDay News) — Verapamil partially preserves stimulated C-peptide secretion at 52 weeks after diagnosis among children with newly diagnosed type 1 diabetes, according to a study published online Feb. 24 in the Journal of th…
Learn MoreClinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated h…
Learn MoreType 1 Diabetes and Use of ‘Off-Label’ Drugs: Benefits, but Concerns, Too
MONDAY, Feb. 20, 2023 (HealthDay News) — While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study.Type 1 diabetes …
Learn MoreLas personas con diabetes tipo 1 no son ni más ni menos propensas a tener sobrepeso, según un estudio
MARTES, 14 de febrero de 2023 (HealthDay News) — Hace mucho que se considera a la diabetes tipo 1 como una enfermedad de las personas delgadas, pero un nuevo estudio cuestiona esa idea.Alrededor de un 62 por ciento de los adultos con diabetes tipo 1 …
Learn More